| Product NDC: | 10019-953 |
| Proprietary Name: | MESNA |
| Non Proprietary Name: | MESNA |
| Active Ingredient(s): | 100 mg/mL & nbsp; MESNA |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 10019-953 |
| Labeler Name: | Baxter Healthcare Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019884 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19881230 |
| Package NDC: | 10019-953-01 |
| Package Description: | 1 VIAL, MULTI-DOSE in 1 BOX (10019-953-01) > 10 mL in 1 VIAL, MULTI-DOSE |
| NDC Code | 10019-953-01 |
| Proprietary Name | MESNA |
| Package Description | 1 VIAL, MULTI-DOSE in 1 BOX (10019-953-01) > 10 mL in 1 VIAL, MULTI-DOSE |
| Product NDC | 10019-953 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | MESNA |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19881230 |
| Marketing Category Name | NDA |
| Labeler Name | Baxter Healthcare Corporation |
| Substance Name | MESNA |
| Strength Number | 100 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Cytoprotective Agent [EPC] |